You are here

P&T August 2019 ePub


Health Care & Law
How does the Patient Protection and Affordable Care Act (ACA) of 2010 differ from the act as it stands today? Many changes have occurred, in Medicaid expansion, private insurance coverage, the American Health Benefit Exchanges, and the individual mandate.
How a pharmacist-driven termination protocol effectively reduced the inappropriate use of acid-suppressive medications, with little impact on pharmacist workflow.
In the case of atypical, long-acting injectable (LAI) antipsychotics, billing under the medical benefit option can cause a significant financial loss. By switching to billing under the pharmacy benefit option, savings can be made in some cases when the use of LAIs and other costly medications is required.
Administering oncology medications has shifted from the inpatient to the outpatient setting because of new, minimal-toxicity regimens, rising drug costs, and a movement toward value-based care. As payer reimbursements decrease, healthcare organizations must find ways to reduce costs while maintaining high-quality services.


Prescription: Washington
Congressional deliberations over several competing bills on drug-price transparency may generate some useful data but are unlikely to have any effect on prices.
Medication Errors
Using chloral hydrate carries a risk of adverse events and compounding errors, and much of the available literature recommends using alternative sedatives for pediatric patients. But evidence regarding the efficacy of chloral hydrate and of alternative agents is conflicting.
Approvals, new indications and formulations, and safety issues
Drug Forecast
Perseris: A new, long-acting, atypical antipsychotic drug-delivery system